General Description
Metrizoate meglumine is an ionic, high-osmolality, tri-iodinated contrast medium used for diagnostic imaging procedures. The drug was employed in angiography, urography, and computed tomography (CT) enhancement but has been largely replaced by non-ionic low-osmolality agents.
Mechanism of Action
Metrizoate contains three iodine atoms per molecule, which attenuate X-rays more effectively than soft tissue. Following intravascular injection, it rapidly distributes in the extracellular fluid and is excreted unchanged by the kidneys via glomerular filtration. The high osmolality of the solution (about 1500 mOsm/kg) causes osmotic diuresis and endothelium-derived vasodilation.
Application
Metrizoate meglumine was indicated for intravenous urography, peripheral arteriography, and contrast-enhanced CT scanning.